Search Page

1

Cite

Share

Nontuberculous mycobacteria infections in immunosuppressed hosts.

Henkle E, Winthrop KL. Henkle E, et al. Clin Chest Med. 2015 Mar;36(1):91-9. doi: 10.1016/j.ccm.2014.11.002. Epub 2014 Dec 23. Clin Chest Med. 2015. PMID:25676522 Free PMC article. Review.

Cite

Share

2

Cite

Share

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

O'Brien KL, Wolfson LJ, Watt JP,Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T; Hib and Pneumococcal Global Burden of Disease Study Team. O'Brien KL, et al. Among authors:henkle e. Lancet. 2009 Sep 12;374(9693):893-902. doi: 10.1016/S0140-6736(09)61204-6. Lancet. 2009. PMID:19748398 Review.

Cite

Share

3

Cite

Share

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.

Henkle E, Curtis JR, Chen L, Chan B, Aksamit TR, Daley CL, Griffith DE, Winthrop KL. Henkle E, et al. Eur Respir J. 2019 Jul 18;54(1):1801896. doi: 10.1183/13993003.01896-2018. Print 2019 Jul. Eur Respir J. 2019. PMID:31000676 Free article.

Cite

Share

4

Cite

Share

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA,Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM. Daniel-Wayman S, et al. Among authors:henkle e. Am J Respir Crit Care Med. 2019 Apr 15;199(8):947-951. doi: 10.1164/rccm.201807-1273PP. Am J Respir Crit Care Med. 2019. PMID:30428263 Free PMC article. No abstract available.

Cite

Share

5

Cite

Share

Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement forPseudomonas aeruginosaIgG response.

Skopelja-Gardner S, Theprungsirikul J, Meagher RE, Beliveau CM, Bradley KE, Avery M,Henkle E, Siegel S, Gifford AH, Winthrop KL, Rigby WFC. Skopelja-Gardner S, et al. Among authors:henkle e. Eur Respir J. 2019 Feb 7;53(2):1801891. doi: 10.1183/13993003.01891-2018. Print 2019 Feb. Eur Respir J. 2019. PMID:30385530 Free article. No abstract available.

Cite

Share

6

Cite

Share

US Patient-Centered Research Priorities and Roadmap for Bronchiectasis.

Henkle E, Aksamit TR, Daley CL, Griffith DE, O'Donnell AE, Quittner AL, Malanga E, Prieto D, Leitman A, Winthrop KL. Henkle E, et al. Chest. 2018 Nov;154(5):1016-1023. doi: 10.1016/j.chest.2018.06.032. Epub 2018 Jul 5. Chest. 2018. PMID:29981718

Cite

Share

7

Cite

Share

Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease.

Henkle E, Winthrop KL, Ranches GP, Plinke W, Litvin HK, Quittner AL. Henkle E, et al. Eur Respir J. 2020 Jan 16;55(1):1901300. doi: 10.1183/13993003.01300-2019. Print 2020 Jan. Eur Respir J. 2020. PMID:31619467

Cite

Share

8

Cite

Share

Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007-2012.

Varley CD, Ku JH,Henkle E, Schafer SD, Winthrop KL. Varley CD, et al. Among authors:henkle e. Emerg Infect Dis. 2017 Mar;23(3):533-535. doi: 10.3201/eid2303.161708. Emerg Infect Dis. 2017. PMID:28221103 Free PMC article.

Cite

Share

9

Cite

Share

Surveillance of Extrapulmonary Nontuberculous Mycobacteria Infections, Oregon, USA, 2007-2012.

Henkle E, Hedberg K, Schafer SD, Winthrop KL. Henkle E, et al. 紧急情况感染说。2017年10月;23(10):1627 - 1630。doi:10.3201/eid2310.170845. Emerg Infect Dis. 2017. PMID:28930014 Free PMC article.

Cite

Share

10

Cite

Share

The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.

Novosad S,Henkle E, Winthrop KL. Novosad S, et al. Among authors:henkle e. Curr Pulmonol Rep. 2015 Sep 1;4(3):152-161. doi: 10.1007/s13665-015-0119-3. Epub 2015 Jul 12. Curr Pulmonol Rep. 2015. PMID:26877911 Free PMC article.

Cite

Share